Apolipoprotein L-I is the trypanosome lytic factor of human serum - sprookjes - yvandenbroek - TriplyDB

Apolipoprotein L-I is the trypanosome lytic factor of human serum

Apolipoprotein L-I is the trypanosome lytic factor of human serum

http://www.wikidata.org/entity/Q24297009

about

Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1 Hemoglobin is a co-factor of human trypanosome lytic factor A single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin-hemoglobin receptor abolishes TLF-1 binding C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense Initial sequence of the chimpanzee genome and comparison with the human genome Association of trypanolytic ApoL1 variants with kidney disease in African Americans Structure of the trypanosome haptoglobin-hemoglobin receptor and implications for nutrient uptake and innate immunity APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy APOL1 localization in normal kidney and nondiabetic kidney disease Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum Immune Evasion Strategies of Trypanosoma brucei within the Mammalian Host: Progression to Pathogenicity Host Intracellular Signaling Events and Pro-inflammatory Cytokine Production in African Trypanosomiasis APOL1 Kidney Disease Risk Variants: An Evolving Landscape Trypanosoma cruzi infection and host lipid metabolism Kidney disease: new technologies translate mechanisms to cure Proteomics investigations of HDL: challenges and promise Trypanosome resistance to human innate immunity: targeting Achilles' heel APOL1 kidney risk alleles: population genetics and disease associations The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease Genetic control of resistance to Trypanosoma brucei brucei infection in mice Knockdown of ApoL1 in Zebrafish Larvae Affects the Glomerular Filtration Barrier and the Expression of Nephrin Structural basis for trypanosomal haem acquisition and susceptibility to the host innate immune system APOL1 toxin, innate immunity, and kidney injury The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects Trypanosoma brucei gambiense group 1 is distinguished by a unique amino acid substitution in the HpHb receptor implicated in human serum resistance In-silico investigation of antitrypanosomal phytochemicals from Nigerian medicinal plants Cathepsin-L can resist lysis by human serum in Trypanosoma brucei brucei Trypanosoma evansi and surra: a review and perspectives on transmission, epidemiology and control, impact, and zoonotic aspects Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.Genetic recombination between human and animal parasites creates novel strains of human pathogen.Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1 Extracellular Vesicles from Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host Anemia Isolation of the repertoire of VSG expression site containing telomeres of Trypanosoma brucei 427 using transformation-associated recombination in yeast.Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes.A Gambian infant with fever and an unexpected blood film

P2860

0b3c21b019bcde04f0778a3b5ddc1b21c55e992b 19a5cf66779f2ec68521a34a9166bcb4a3d064ad

P248

Q21092282-7AF5BA04-C02E-4652-BEBE-24A15E918E4E Q21131604-5F44DD96-146F-4175-AFB5-664C4B8F3FD3 Q21558778-202F81CD-6988-4B1B-910C-32D6CE8FF7DC Q21559412-DE6EA721-8F64-4669-9281-21D3621DDCE9 Q22122468-5AC0E9A5-DDF9-4724-8426-1C2EB146236D Q24606581-503A6BD0-78C5-42DE-B120-02E297E44436 Q24628085-67A74A6C-8F4B-40CF-ADEC-2E018FF6CC2B Q24631837-2D692ADC-0D20-41E6-8688-B1241B90FAC9 Q24631960-2A84C2D7-741B-4E3F-83C8-65AF2509F5F1 Q24632288-584C18C8-B9D7-4F24-B65B-B791FB5ADE33 Q24651930-CD54FD3A-FF95-45F6-833A-9D525F42D199 Q24652930-6DD0C733-D163-4927-98B4-FDA845A57047 Q24652950-ED483090-BFB2-4CB8-8102-0AEE2A329EA3 Q24681132-E7E8D55D-2EF2-4673-807F-E8BED0626BA1 Q26742172-0A144A6D-9910-47A7-AD60-D4D7A79D9E2B Q26744647-1C0767F1-6530-4B93-8010-280C0962995A Q26799191-E46B1643-567A-45E4-A39F-97D3694DE652 Q26823791-D19E5E8C-3D9D-4BD4-A9E8-224B596197C8 Q26825227-7F975950-7463-4BE5-BA1C-ADC223C7E090 Q27000995-593EA6F0-5DEE-486E-9480-2E2E18FCCABE Q27006982-D7486C90-C178-4C2C-B507-13F1CE36F39F Q27024261-1D28CC65-B92F-4A66-9F8D-0E62406BDCDF Q27027828-1DEFA02E-3D66-4620-A8E0-EEE092559F4B Q27306175-1AF78C6B-E476-4931-9B31-79CA2737B37B Q27313326-EC6B0342-77FD-4963-94FF-729038331FF9 Q27696195-4C30306E-8C7A-4C49-86DC-13E7503D1F82 Q28085667-EB9C2A32-973A-400D-A97C-F2F5DAE2B088 Q28388695-1BD730CA-AA9C-4F5B-93DF-C77C38168CA6 Q28481228-62095B37-5CFA-4B46-BDA3-60E2F5F81E19 Q28481512-0553968E-1F62-41BC-B389-E4ABB520B85C Q28538908-9ADD1431-14B3-46F4-B8BF-31197EFD32ED Q28677323-26FEDCCC-8B74-4C53-8DA5-1D157532F50A Q28750412-25222D3E-D36E-4BF4-82CC-CA1630BA4C35 Q30279056-F291B95D-BA72-4726-9E9E-5B2EC5D197E8 Q30373132-775AF98F-6944-4E82-84AB-F35C4B4BBA42 Q30663833-CE62A8DD-5015-4F84-AD89-C936EC1017C5 Q30698901-B8FE7F52-B07D-4A4B-9930-08CA3643F61B Q33208595-61C799CF-5E81-4E96-9A03-E06769FC003B Q33220401-25A51066-7613-4DEB-ABA7-147293FD72C3 Q33258475-94D7EE13-5B1E-4AD4-B4C3-0CB04FC426B7

P2860

Apolipoprotein L-I is the trypanosome lytic factor of human serum

http://www.wikidata.org/entity/Q24297009

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Apolipoprotein L-I is the trypanosome lytic factor of human serum

@ast

Apolipoprotein L-I is the trypanosome lytic factor of human serum

@en

Apolipoprotein L-I is the trypanosome lytic factor of human serum

@en-gb

Apolipoprotein L-I is the trypanosome lytic factor of human serum

@nl

type

label

Apolipoprotein L-I is the trypanosome lytic factor of human serum

@ast

Apolipoprotein L-I is the trypanosome lytic factor of human serum

@en

Apolipoprotein L-I is the trypanosome lytic factor of human serum

@en-gb

Apolipoprotein L-I is the trypanosome lytic factor of human serum

@nl

prefLabel

Apolipoprotein L-I is the trypanosome lytic factor of human serum

@ast

Apolipoprotein L-I is the trypanosome lytic factor of human serum

@en

Apolipoprotein L-I is the trypanosome lytic factor of human serum

@en-gb

Apolipoprotein L-I is the trypanosome lytic factor of human serum

@nl

P1433

Q24297009-D0991CC5-C935-4E19-9B29-5CD64290D48A

P1476

Q24297009-6A66DD17-2F44-44AF-A2EC-469848B4EDFD

P2093

Q24297009-1FE56A87-BCC4-43E7-B549-887EA2E05C39

Q24297009-209C02B7-986B-4BC6-BF3A-BFBA23761539

Q24297009-446534BE-3861-4B43-BE16-76B353365772

Q24297009-512FF861-3E3F-4AD3-81AB-EDF085F4C24D

Q24297009-80AE7E30-ED20-4839-9517-1DCA340D1744

Q24297009-A78CAA55-12AC-427D-A75D-2D57B6A733B9

Q24297009-FEE1FF03-C2A6-4DCA-9A46-384FA5117BA6

P2888

Q24297009-C12C8033-6F6F-4893-AA5F-12E7148917B2

P304

Q24297009-FD332E5A-6FA0-415D-90A0-DE8B01CC29BB

P31

Q24297009-B938B9B9-2435-40E8-BE51-BF110BAA897D

P3181

Q24297009-8C53E14B-CA88-4787-8BD2-BA2B7182D5E6

P356

Q24297009-BEAC2B38-AF1D-446F-AB9A-41D76FC1511D

P407

Q24297009-D7108115-4672-4D5B-BF5B-CCD28DA0BDD4

P433

Q24297009-9CD8604E-9D08-4DD0-A7BF-F56D2AD87FAB

P478

Q24297009-4135F48C-1965-4706-9E14-EA6C216E4B79

P50

Q24297009-0D428C64-57D0-47F8-A55E-2CC7E71466FF

Q24297009-1DCDE5D8-A263-4A83-9028-23F0C6DC5C53

Q24297009-3061E3B1-456B-489C-8F32-E7FECD0E64E2

Q24297009-49F509FB-5B8A-41D9-BEE9-F08429DABF6E

Q24297009-5F3DF791-1723-4251-A2DA-311C90CD3868

Q24297009-9F359C5E-C947-4996-A80D-32112CE018B8

Q24297009-A7AF511E-E6B0-4765-90B9-3E71520AAE7F

Q24297009-DF10C428-5286-405D-9E36-F30A0865D4C9

Q24297009-F50B0D94-B4EB-4FF8-BEE6-C8E6089C5ACA

P577

Q24297009-6E87A8D5-8082-4665-AEF7-13A1EA509760

P6179

Q24297009-0A693815-999D-43B6-AC75-616BBEB77E06

P698

Q24297009-2DF1F20D-EAF4-4C5D-AD28-F7570E08B909

P921

Q24297009-3A0CAA56-27A2-437E-8C95-022BD9FFA88D

Q24297009-D84A02AC-D6C9-4BBF-BC7C-3AA5F8B46D88

P3181

P356

P1433

P1476

Apolipoprotein L-I is the trypanosome lytic factor of human serum

@en

P2093

Alain Jacquet

http://www.w3.org/2001/XMLSchema#string

Annette Pays

http://www.w3.org/2001/XMLSchema#string

Huang Van Xong

http://www.w3.org/2001/XMLSchema#string

John P Kane

http://www.w3.org/2001/XMLSchema#string

Marc Dieu

http://www.w3.org/2001/XMLSchema#string

Patricia Tebabi

http://www.w3.org/2001/XMLSchema#string

Robert Brasseur

http://www.w3.org/2001/XMLSchema#string

P2888

P304

83-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

516811

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE01461

http://www.w3.org/2001/XMLSchema#string

P407

P433

6927

http://www.w3.org/2001/XMLSchema#string

P478

422

http://www.w3.org/2001/XMLSchema#string

P50

Patrick De Baetselier

Nicole Moguilevsky

Françoise Paturiaux-Hanocq

Jan Van Den Abbeele

Philippe Poelvoorde

P577

2003-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051972215

http://www.w3.org/2001/XMLSchema#string

P698

12621437

http://www.w3.org/2001/XMLSchema#string

P921

Apolipoprotein L1

cytolysis by host of symbiont cells